194 related articles for article (PubMed ID: 38259671)
1. Study of miRNA and lymphocyte subsets as potential biomarkers for the diagnosis and prognosis of gastric cancer.
Li J; Chen Z; Li Q; Liu R; Zheng J; Gu Q; Xiang F; Li X; Zhang M; Kang X; Wu R
PeerJ; 2024; 12():e16660. PubMed ID: 38259671
[TBL] [Abstract][Full Text] [Related]
2. Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers.
Varkalaite G; Vaitkeviciute E; Inciuraite R; Salteniene V; Juzenas S; Petkevicius V; Gudaityte R; Mickevicius A; Link A; Kupcinskas L; Leja M; Kupcinskas J; Skieceviciene J
World J Gastroenterol; 2022 Feb; 28(6):653-663. PubMed ID: 35317427
[TBL] [Abstract][Full Text] [Related]
3. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
4. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
5. MiR 21-5p as a predictor of recurrence in young gastric cancer patients.
Park SK; Park YS; Ahn JY; Do EJ; Kim D; Kim JE; Jung K; Byeon JS; Ye BD; Yang DH; Park SH; Hwang SW; Jung HY; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1429-35. PubMed ID: 26824898
[TBL] [Abstract][Full Text] [Related]
6. Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia.
Kim YJ; Hwang KC; Kim SW; Lee YC
Int J Med Sci; 2018; 15(6):610-616. PubMed ID: 29725252
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA hsa_circ_0001829 promotes gastric cancer progression through miR-155-5p/SMAD2 axis.
Niu Q; Dong Z; Liang M; Luo Y; Lin H; Lin M; Zhong X; Yao W; Weng J; Zhou X
J Exp Clin Cancer Res; 2020 Dec; 39(1):280. PubMed ID: 33308284
[TBL] [Abstract][Full Text] [Related]
8. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
[TBL] [Abstract][Full Text] [Related]
9. miRNAs as potential biomarkers for the progression of gastric cancer inhibit CREBZF and regulate migration of gastric adenocarcinoma cells.
Kim YJ; Jeong S; Jung WY; Choi JW; Hwang KC; Kim SW; Lee YC
Int J Med Sci; 2020; 17(6):693-701. PubMed ID: 32218690
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
11. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
12. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
13. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.
Tan Y; Ge G; Pan T; Wen D; Gan J
Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130
[TBL] [Abstract][Full Text] [Related]
14. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
Zheng L; Wang J; Jiang H; Dong H
Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
[TBL] [Abstract][Full Text] [Related]
15. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
[TBL] [Abstract][Full Text] [Related]
16. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
[TBL] [Abstract][Full Text] [Related]
17. miRNAs derived from plasma small extracellular vesicles predict organo-tropic metastasis of gastric cancer.
Zhang C; Yang J; Chen Y; Jiang F; Liao H; Liu X; Wang Y; Kong G; Zhang X; Li J; Gao J; Shen L
Gastric Cancer; 2022 Mar; 25(2):360-374. PubMed ID: 35031872
[TBL] [Abstract][Full Text] [Related]
18. Combination of Four Serum Exosomal MiRNAs as Novel Diagnostic Biomarkers for Early-Stage Gastric Cancer.
Tang S; Cheng J; Yao Y; Lou C; Wang L; Huang X; Zhang Y
Front Genet; 2020; 11():237. PubMed ID: 32256526
[TBL] [Abstract][Full Text] [Related]
19. Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma.
Wu J; Feng Z; Wang R; Li A; Wang H; He X; Shen Z
Cancer Med; 2022 Dec; 11(23):4411-4421. PubMed ID: 35585716
[TBL] [Abstract][Full Text] [Related]
20. [Bioinformatics analysis of the microRNA expression profile in the peripheral blood lymphocytes of Kazakh patients with essential hypertension in Xinjiang].
Wang Y; Zhang L; Yang R; Shan LY; Wang L; Zhang YY; Li XZ; Ma KT
Sheng Li Xue Bao; 2022 Oct; 74(5):751-762. PubMed ID: 36319098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
